Skip to main content

Lisdexamfetamine Dimesylate Capsules Shortage

Last Updated: June 6, 2024
Status: Current

Products Affected - Description
    • Lisdexamfetamine dimesylate oral capsule, Alvogen, 10 mg, bottle, 100 count, NDC 47781-0562-01
    • Lisdexamfetamine dimesylate oral capsule, Alvogen, 20 mg, bottle, 100 count, NDC 47781-0563-01
    • Lisdexamfetamine dimesylate oral capsule, Alvogen, 30 mg, bottle, 100 count, NDC 47781-0564-01
    • Lisdexamfetamine dimesylate oral capsule, Alvogen, 40 mg, bottle, 100 count, NDC 47781-0565-01
    • Lisdexamfetamine dimesylate oral capsule, Alvogen, 50 mg, bottle, 100 count, NDC 47781-0566-01
    • Lisdexamfetamine dimesylate oral capsule, Alvogen, 60 mg, bottle, 100 count, NDC 47781-0567-01
    • Lisdexamfetamine dimesylate oral capsule, Alvogen, 70 mg, bottle, 100 count, NDC 47781-0568-01
    • Lisdexamfetamine dimesylate oral capsule, Amneal, 20 mg, bottle, 90 count, NDC 65162-0023-09
    • Lisdexamfetamine dimesylate oral capsule, Amneal, 30 mg, bottle, 90 count, NDC 65162-0024-09
    • Lisdexamfetamine dimesylate oral capsule, Amneal, 40 mg, bottle, 90 count, NDC 65162-0025-09
    • Lisdexamfetamine dimesylate oral capsule, Amneal, 50 mg, bottle, 90 count, NDC 65162-0026-09
    • Lisdexamfetamine dimesylate oral capsule, Amneal, 60 mg, bottle, 90 count, NDC 65162-0027-09
    • Lisdexamfetamine dimesylate oral capsule, Amneal, 70 mg, bottle, 90 count, NDC 65162-0028-09
    • Lisdexamfetamine dimesylate oral capsule, Hikma, 20 mg, bottle, 100 count, NDC 00054-0370-25
    • Lisdexamfetamine dimesylate oral capsule, Hikma, 30 mg, bottle, 100 count, NDC 00054-0371-25
    • Lisdexamfetamine dimesylate oral capsule, Hikma, 40 mg, bottle, 100 count, NDC 00054-0372-25
    • Lisdexamfetamine dimesylate oral capsule, Hikma, 50 mg, bottle, 100 count, NDC 00054-0373-25
    • Lisdexamfetamine dimesylate oral capsule, Hikma, 60 mg, bottle, 100 count, NDC 00054-0374-25
    • Lisdexamfetamine dimesylate oral capsule, Hikma, 70 mg, bottle, 100 count, NDC 00054-0375-25
    • Lisdexamfetamine dimesylate oral capsule, Lannett, 10 mg, bottle, 100 count, NDC 00527-4661-37
    • Lisdexamfetamine dimesylate oral capsule, Lannett, 20 mg, bottle, 100 count, NDC 00527-4662-37
    • Lisdexamfetamine dimesylate oral capsule, Lannett, 30 mg, bottle, 100 count, NDC 00527-4663-37
    • Lisdexamfetamine dimesylate oral capsule, Lannett, 40 mg, bottle, 100 count, NDC 00527-4664-37
    • Lisdexamfetamine dimesylate oral capsule, Lannett, 50 mg, bottle, 100 count, NDC 00527-4665-37
    • Lisdexamfetamine dimesylate oral capsule, Lannett, 60 mg, bottle, 100 count, NDC 00527-4666-37
    • Lisdexamfetamine dimesylate oral capsule, Lannett, 70 mg, bottle, 100 count, NDC 00527-4667-37
    • Lisdexamfetamine dimesylate oral capsule, Rhodes, 10 mg, bottle, 100 count, NDC 42858-0161-01
    • Lisdexamfetamine dimesylate oral capsule, Rhodes, 20 mg, bottle, 100 count, NDC 42858-0162-01
    • Lisdexamfetamine dimesylate oral capsule, Rhodes, 30 mg, bottle, 100 count, NDC 42858-0163-01
    • Lisdexamfetamine dimesylate oral capsule, Rhodes, 40 mg, bottle, 100 count, NDC 42858-0164-01
    • Lisdexamfetamine dimesylate oral capsule, Rhodes, 50 mg, bottle, 100 count, NDC 42858-0165-01
    • Lisdexamfetamine dimesylate oral capsule, Rhodes, 60 mg, bottle, 100 count, NDC 42858-0166-01
    • Lisdexamfetamine dimesylate oral capsule, Rhodes, 70 mg, bottle, 100 count, NDC 42858-0167-01
    • Lisdexamfetamine dimesylate oral capsule, Solco Healthcare US, 10 mg, bottle, 100 count, NDC 43547-0602-10
    • Lisdexamfetamine dimesylate oral capsule, Solco Healthcare US, 20 mg, bottle, 100 count, NDC 43547-0603-10
    • Lisdexamfetamine dimesylate oral capsule, Solco Healthcare US, 30 mg, bottle, 100 count, NDC 43547-0604-10
    • Lisdexamfetamine dimesylate oral capsule, Solco Healthcare US, 40 mg, bottle, 100 count, NDC 43547-0605-10
    • Lisdexamfetamine dimesylate oral capsule, Solco Healthcare US, 50 mg, bottle, 100 count, NDC 43547-0606-10
    • Lisdexamfetamine dimesylate oral capsule, Solco Healthcare US, 60 mg, bottle, 100 count, NDC 43547-0607-10
    • Lisdexamfetamine dimesylate oral capsule, Solco Healthcare US, 70 mg, bottle, 100 count, NDC 43547-0608-10
    • Lisdexamfetamine dimesylate oral capsule, Sun Pharma, 10 mg, bottle, 100 count, NDC 57664-0046-88
    • Lisdexamfetamine dimesylate oral capsule, Sun Pharma, 20 mg, bottle, 100 count, NDC 57664-0047-88
    • Lisdexamfetamine dimesylate oral capsule, Sun Pharma, 30 mg, bottle, 100 count, NDC 57664-0048-88
    • Lisdexamfetamine dimesylate oral capsule, Sun Pharma, 40 mg, bottle, 100 count, NDC 57664-0049-88
    • Lisdexamfetamine dimesylate oral capsule, Sun Pharma, 50 mg, bottle, 100 count, NDC 57664-0050-88
    • Lisdexamfetamine dimesylate oral capsule, Sun Pharma, 60 mg, bottle, 100 count, NDC 57664-0051-88
    • Lisdexamfetamine dimesylate oral capsule, Sun Pharma, 70 mg, bottle, 100 count, NDC 57664-0052-88
Reason for the Shortage
    • Alvogen has lisdexamfetamine capsules on shortage due to regulatory delays.
    • Amneal has lisdexamfetamine capsules on shortage due to an issue with the active ingredient.
    • Hikma has lisdexamfetamine capsules on shortage due to an issue with the active ingredient.
    • Lannett did not provide a reason for the shortage.
    • Mallinckrodt does not provide information on drug shortages.
    • Mylan has lisdexamfetamine capsules available.
    • Rhodes launched lisdexamfetamine 30 mg, 40 mg, 50 mg, 60 mg, and 70 mg capsules in March 2024. The 10 mg and 20 mg capsules have not been launched and the company cannot estimate a release date.
    • Solco has lisdexamfetamine capsules on shortage due to an issue with the active ingredient.
    • Sun Pharma has lisdexamfetamine capsules on shortage due to regulatory delays.
    • Takeda has Vyvanse available.
Available Products
    • Vyvanse oral capsule, Takeda, 10 mg, bottle, 100 count, NDC 59417-0101-10
    • Vyvanse oral capsule, Takeda, 20 mg, bottle, 100 count, NDC 59417-0102-10
    • Vyvanse oral capsule, Takeda, 30 mg, bottle, 100 count, NDC 59417-0103-10
    • Vyvanse oral capsule, Takeda, 40 mg, bottle, 100 count, NDC 59417-0104-10
    • Vyvanse oral capsule, Takeda, 50 mg, bottle, 100 count, NDC 59417-0105-10
    • Vyvanse oral capsule, Takeda, 60 mg, bottle, 100 count, NDC 59417-0106-10
    • Vyvanse oral capsule, Takeda, 70 mg, bottle, 100 count, NDC 59417-0107-10
    • Lisdexamfetamine dimesylate oral capsule, Mylan (Viatris), 10 mg, bottle, 90 count, NDC 00378-6854-77
    • Lisdexamfetamine dimesylate oral capsule, Mylan (Viatris), 20 mg, bottle, 90 count, NDC 00378-6855-77
    • Lisdexamfetamine dimesylate oral capsule, Mylan (Viatris), 30 mg, bottle, 90 count, NDC 00378-6856-77
    • Lisdexamfetamine dimesylate oral capsule, Mylan (Viatris), 40 mg, bottle, 90 count, NDC 00378-6857-77
    • Lisdexamfetamine dimesylate oral capsule, Mylan (Viatris), 50 mg, bottle, 90 count, NDC 00378-6858-77
    • Lisdexamfetamine dimesylate oral capsule, Mylan (Viatris), 60 mg, bottle, 90 count, NDC 00378-6859-77
    • Lisdexamfetamine dimesylate oral capsule, Mylan (Viatris), 70 mg, bottle, 90 count, NDC 00378-6860-77

Estimated Resupply Dates

    • Alvogen has lisdexamfetamine 20 mg, 30 mg, 60 mg, and 70 mg capsules available in limited supply. The 10 mg, 40 mg and 50 mg capsules are on back order and the company cannot estimate a release date.
    • Amneal has lisdexamfetamine capsules on back order and the company cannot estimate a release date.
    • Hikma has lisdexamfetamine 20 mg, 30 mg, 40 mg, 50 mg, and 70 mg capsules on allocation. Lisdexamfetamine 60 mg capsules are on back order and the company estimates a release date in mid-June 2024.
    • Lannett has lisdexamfetamine 10 mg, 20 mg, 30 mg, and 40 mg capsules on allocation. Lisdexamfetamine 50 mg, 60 mg, and 70 mg capsules are on back order and the company cannot estimate a release date.
    • Rhodes has all lisdexamfetamine on back order and the company cannot estimate a release date.
    • Solco has lisdexamfetamine capsules on back order and the company cannot estimate a release date.
    • Sun Pharma has all lisdexamfetamine presentations on back order and the company estimates additional product will be available in late-June 2024.

Alternative Agents & Management

    • Vyvanse chewable tablets are not affected by this shortage.

Updated

Updated June 6, 2024 by Elyse MacDonald, PharmD, MS, BCPS. Created June 19, 2023 by Leslie Jensen, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer